Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIITerminatedJul 23, 2014VelivetFailed Impurities/Degradation Specifications: out of specification impurity test results.Teva Pharmaceuticals USA · D-1439-2014Class IIITerminatedJul 23, 2014Kariva (desogestrel/ethinyl estradiol and ethinyl estradiol) Tablets 0.15 mg/0.02 mg and 0.01 mgFailed Impurities/Degradation Specifications: out of specification impurity test results.Teva Pharmaceuticals USA · D-1438-2014Class IIITerminatedJul 23, 2014MircetteFailed Impurities/Degradation Specifications: out of specification impurity test results.Teva Pharmaceuticals USA · D-1437-2014Class IIITerminatedJul 23, 2014Apri (desogestrel and ethinyl estradiol tablets USP)Failed Impurities/Degradation Specifications: out of specification impurity test results.Teva Pharmaceuticals USA · D-1436-2014Class IIITerminatedJul 23, 2014Diltiazem HCl Extended-release CapsulesFailed Impurities/Degradation Specifications: High out-of-specification results for a related compound obtained during routine stability testing.Mylan Institutional, Inc. (d.b.a. UDL Laboratories) · D-1435-2014Class IITerminatedJul 23, 2014Hemo-Stat SolutionMarketed without an Approved NDA/ANDA; product is being manufactured and distributed without a NDC numberAxcentria Pharmaceuticals, LLC · D-1434-2014Class IITerminatedJul 23, 2014Fentanyl Citrate InjectionLack of Assurance of Sterility: Fliptop vial crimps are loose or missing.Hospira Inc. · D-1433-201Class IIITerminatedJul 23, 2014LORTUSS EXDoes Not Meet Monograph: Phenylephrine and pseudoephedrine are below monograph specifications, and label inaccurately contains wording "Rx Only".Poly Pharmaceuticals, Inc · D-1432-2014Class IIITerminatedJul 23, 2014POLY-TUSSIN AC LIQUIDDoes Not Meet Monograph: Phenylephrine and pseudoephedrine are below monograph specifications, and label inaccurately contains wording "Rx Only".Poly Pharmaceuticals, Inc · D-1431-2014Class IITerminatedJul 16, 2014Fluvastatin Capsules USPFailed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, Inc. is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to a customer complaint...Teva Pharmaceuticals USA · D-1430-2014Class IITerminatedJul 16, 2014Fosphenytoin Sodium InjectionPresence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.Fresenius Kabi USA, LLC · D-1429-2014Class IITerminatedJul 16, 2014Fosphenytoin Sodium InjectionPresence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.Fresenius Kabi USA, LLC · D-1428-2014Class IITerminatedJul 16, 2014Calcitriol Oral Solution 1 mcg/mLFailed Impurity/Degradation Specification; out of specification for trans-calcitriol degradant at the 9 month stability time pointBoehringer Ingelheim Roxane Inc · D-1427-2014Class IIITerminatedJul 16, 2014ENDOMETRINDiscoloration; due to prolonged heat exposure.Ferring Pharmaceuticals Inc · D-1426-2014Class IITerminatedJul 16, 2014Heparin Sodium in 5% Dextrose InjectionLack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.Hospira Inc. · D-1425-2014Class IITerminatedJul 16, 2014Labetalol Hydrochloride InjectionPresence of Particulate Matter; metal embedded in the glass vial and visible particles floating in the solutionHospira Inc. · D-1424-2014Class IITerminatedJul 16, 2014Tyvaso (treprostinil) Inhalation SolutionDefective Delivery System: United Therapeutics is voluntarily recalling a small number of Tyvaso Inhalation Systems with Optineb ON-100/7 and TD-100/A medical devices...United Therapeutics Corp. · D-1423-2014Class IITerminatedJul 16, 2014BUPivacaine HCl 0.25% Preservative FreePresence of Particulate Matter: The bupivacaine HCl injection used to compound this lot of BUPivacaine HCl 0.25% Preservative Free 500 mL in On-Q C-bloc was recalled by...Healix Infusion Therapy, Inc. · D-1422-2014Class IITerminatedJul 9, 2014HCG (Human Chorionic Gonadotropin) + MethylcobalaminIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1421-2014Class IITerminatedJul 9, 2014HCG (Human Chorionic Gonadotropin) 200 units/ 0.1 mL dropsIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1420-2014Class IITerminatedJul 9, 2014HCG 125U/Tab Tablet TrituIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1419-2014Class IITerminatedJul 9, 2014HCG (Human Chorionic Gonadotropin) 125 units/ 0.1 mL dropIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1418-2014Class IITerminatedJul 9, 2014DiphenhydramineIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1417-2014Class IITerminatedJul 9, 2014Mometasone 0.6 mg /60 mL Irrigation solutionIncorrect/Undeclared Excipients: Specific drug products were compounded with an incorrect solvent.Brookfield Prescription Center Inc. dba MD Custom Rx · D-1416-2014Class IITerminatedJul 9, 2014Venlafaxine Hydrochloride Extended-Release TabletsFailed Dissolution Specifications: Stability results found the product did not meet the drug dissolution specifications.Caraco Pharmaceutical Laboratories, Ltd. · D-1415-2014Class IITerminatedJul 9, 2014Isoniazid TabletsFailed Dissolution Specifications: Stability lots cannot support dissolution past the 36 month time point.West-Ward Pharmaceutical Corp. · D-1414-2014Class IITerminatedJul 9, 2014Brevibloc Premixed InjectionPresence of Particulate Matter: Complaints received of discolored solution identified as subvisible particles of iron oxide that are agglomerating.Baxter Healthcare Corp. · D-1413-2014Class IITerminatedJul 9, 2014BystolicFailed Dissolution Specifications: Drug failed stage III dissolution testing.Forest Pharmaceuticals Inc · D-1412-2014Class IITerminatedJul 2, 2014Sodium Chloride Hypertonicity Ophthalmic OintmentCrystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.Bausch & Lomb, Inc. · D-1411-2014Class IITerminatedJul 2, 2014Muro 128Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.Bausch & Lomb, Inc. · D-1410-2014Class IITerminatedJul 2, 2014PristiqPresence of Foreign Tablets/Capsules: Pfizer is recalling 50 mg Pristiq (desvenlafaxine) extended release tablets because a single Pristiq 100 mg tablet was found in a...Pfizer Us Pharmaceutical Group · D-1409-2014Class IITerminatedJul 2, 2014Dextroamphetamine Sulfate TabletsFailed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.Teva Pharmaceuticals USA · D-1408-2014Class IITerminatedJul 2, 2014Gemcitabine For Injection USPLack of Assurance of Sterility: A particle excursion for a different batch of the same product may lead to a lack of sterility assurance.Caraco Pharmaceutical Laboratories, Ltd. · D-1407-2014Class IITerminatedJun 25, 2014Polidocanol 1% Solution for InjectionLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1406-2014Class IITerminatedJun 25, 2014PYRIDOXINE HCLLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1405-2014Class IITerminatedJun 25, 2014LIPOTROPIC GOLDLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1404-2014Class IITerminatedJun 25, 2014Papaverine HCl 30 mgLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1403-2014Class IITerminatedJun 25, 2014Papaverine HCl 30 mgLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1402-2014Class IITerminatedJun 25, 2014Papaverine HCl 30 mgLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1401-2014Class IITerminatedJun 25, 2014Papaverine HCl 30 mgLack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.John W Hollis Inc · D-1400-2014

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.